SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-18-018810
Filing Date
2018-04-17
Accepted
2018-04-17 16:33:07
Documents
7
Period of Report
2018-04-16
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm 8-K 55446
2 EXHIBIT 3.1 ex3_1.htm EX-3.1 7102
3 EXHIBIT 10.1 ex10_1.htm EX-10.1 7263
4 EXHIBIT 99.1 ex99_1.htm EX-99.1 19684
5 image00002.jpg GRAPHIC 45094
6 image00003.jpg GRAPHIC 2515
7 image00004.jpg GRAPHIC 3581
  Complete submission text file 0001140361-18-018810.txt   161802
Mailing Address 2855 GAZELLE CT CARLSBAD CA 92010
Business Address 55 CAMBRIDGE PARKWAY SUITE 100 CAMBRIDGE MA 02142 760-603-2732
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38137 | Film No.: 18759355
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1